Genomic Analysis of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Tertiary Hospital
Lan Chen,Ying Zhou,Shanshan Wang,Chunyang Wu,Peiyao Zhou,Bingjie Wang,Zhu Chen,Fangyou Yu
DOI: https://doi.org/10.2147/idr.s425949
2023-09-28
Infection and Drug Resistance
Abstract:Lan Chen, 1, &ast Ying Zhou, 2, &ast Shanshan Wang, 1 Chunyang Wu, 3 Peiyao Zhou, 4 Bingjie Wang, 2 Zhu Chen, 5 Fangyou Yu 2 1 Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, People's Republic of China; 2 Department of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200082, People's Republic of China; 3 Department of Respiratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China; 4 Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China; 5 Department of Clinical Laboratory Medicine, Ningbo No. 2 Hospital, Ningbo, Zhejiang, 315010, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhu Chen; Fangyou Yu, Email ; Background: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) has become a clinical crisis and is associated with significant morbidity and mortality. The prevalence of CR-hvKP has trended upward since 2010. This study aims to describe the clinical and genomic characteristics of CR-hvKP collected from a tertiary hospital in eastern China, from August 2020 to October 2021. Methods: We tested the susceptibility to common antibiotics in these isolates to feature the antibiotic-resistant phenotypes. We also applied whole-genome sequencing and core-genome phylogenetic to analysis the genetic features of these isolates. Plasmid replicons were identified by using the PlasmidFinder database, and core-genome phylogenetic analysis by Parsnp database. Results: All these strains isolated from the patients with serious underlying diseases and poor prognosis. We found all CR-hvKp isolates exhibited a multidrug-resistant (MDR) phenotype. These results revealed that bla KPC-2 was the predominant carbapenemases gene (n = 53, 84.1%), and ST11-KL64 CR-hvKP strains dominated, forming a single cluster, and differed by an average of 26 core SNPs. We only found eight ST15 isolates containing KL24 and KL112 type capsules, with the main carbapenem resistance genes being bla OXA-232 and bla KPC-2 . All ST11-KL64 strains had a series of resistance and virulence genes, along with IncHIB-FIB virulence plasmids and IncFII resistance plasmids, while the prevalence of resistance plasmids like the IncFII plasmid was absence in ST15 isolates. Conclusion: This suggests that ST11-KL64 CR-hvKP has emerged as the most prevalent hypervirulence and carbapenem-resistant K. pneumoniae and may contribute to hospital outbreaks of infection, which required most clinical attention. Keywords: carbapenem-resistant, hypervirulence, Klebsiella pneumoniae , whole-genome sequencing, antimicrobial resistance, virulence genes Klebsiella pneumoniae (KP) is a common opportunistic pathogen in clinical practice, capable of causing infectious diseases in the urinary tract, respiratory tract, blood, and soft tissues. 1 Hypervirulent Klebsiella pneumoniae (hvKp) has a higher virulence than KP 2 and can cause severe infectious diseases, including pyogenic liver abscess, endophthalmitis, and meningitis. 3,4 Although multidrug resistance and hypervirulence were previously thought to follow distinct evolutionary directions with non-overlapping genomic signatures for each phenotype, 5 hvKp has recently garnered more attention due to its increased likelihood of acquiring antimicrobial resistance (AMR) genes, particularly those that code for carbapenemases. 2,6 Carbapenem-resistant hvKp (CR-hvKp) exhibits both hypervirulence and carbapenem resistance phenotypes, making infections caused by these strains difficult to treat with current antibiotics, and should therefore receive greater attention. 7 CR-hvKP emerged in the early 2010s and is primarily prevalent in Asia, especially China, but cases have been reported worldwide. 8 In 2016, a lethal outbreak of ST11 CR-hvKP occurred in a Chinese intensive care unit, with 21 ST11 KPC-2-producing CR-hvKP strains isolated from five patients who died during hospitalization. 7 CR-hvKP has spread globally and poses a significant human public health threat. 9 Therefore, the early recognition of these hypervirulent strains, including their resistance determinants, is a priority concern. The aim of our study was to determine the current occurrence of CR-hvKp in a ter -Abstract Truncated-
pharmacology & pharmacy,infectious diseases